GH Axis
CJC-1295 (No DAC)
Modified GRF (1-29) · Mod GRF 1-29
Tetra-substituted GHRH(1-29) analogue for pulsatile GH-release research.
2 mg5 mg10 mg
CJC-1295 (No DAC) + Ipamorelin
Also known as: CJC/Ipa blend · GHRH + GHRP stack
Growth Hormone Axis Blend In stock Box of 10 vials 2 references
GHRH analogue plus selective secretagogue — the classic synergistic GH-release pairing.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| CP10 | 10 mg (5 + 5) | 10 vials / box |
Order CJC-1295 (No DAC) + Ipamorelin
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
A 1:1 co-formulation of Modified GRF (1-29) and ipamorelin. The two act on different receptors — the GHRH receptor and the ghrelin/GHS receptor respectively — and their combination is studied for synergistic, pulsatile GH release. Modified GRF(1-29) is the backbone of the CJC-1295 characterised by Teichman et al. 1; ipamorelin's selective secretagogue pharmacology is described by Raun et al. 2.
At a glance
- 5 mg Mod GRF (1-29) + 5 mg ipamorelin per vial
- Dual-receptor GH-release model
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2005;91(3):799-805.
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related
Often ordered together
GH Axis
Ipamorelin
NNC 26-0161 · Selective GH secretagogue
The first selective growth-hormone secretagogue — GH release without cortisol or prolactin.
5 mg10 mg
GH Axis Blend
Tesamorelin + Ipamorelin
Tesa/Ipa blend
Stabilised GHRH analogue paired with the selective GHS-R agonist.
10 mg (5 + 5)20 mg (10 + 10)